Neuropsychiatric Complications of COVID-19

Overview

Journal Curr Psychiatry Rep

Publisher Current Science

Specialty Psychiatry

Date 2021 Mar 16

PMID 33725218

Citations 50

Authors

Zev M Nakamura

Rebekah P Nash

Sarah L Laughon

Donald L Rosenstein

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: To describe the presentation, etiologies, and suggested management of post-acute COVID-19 neuropsychiatric symptoms.

Recent Findings: Over 30% of patients hospitalized with COVID-19 may exhibit cognitive impairment, depression, and anxiety that persist for months after discharge. These symptoms are even more common in patients who required intensive care for severe effects of the virus. In addition to the pandemic-related psychological stress, multiple biological mechanisms have been proposed to understand the neuropsychiatric symptoms observed with COVID-19. Given limited research regarding effective interventions, we recommend pharmacologic and behavioral strategies with established evidence in other medically-ill populations. Long-term, neuropsychiatric complications of COVID-19 are common and consequential. Because these are likely to co-occur with other medical problems, patients recovering from COVID-19 are best managed in clinics with highly coordinated care across disciplines and medical specialties. Future research is needed to inform appropriate interventions.

Citing Articles

Machine learning based predictive modeling and risk factors for prolonged SARS-CoV-2 shedding.

Zhang Y, Li Q, Duan H, Tan L, Cao Y, Chen J J Transl Med. 2024; 22(1):1054.

PMID: 39578848 PMC: 11583424. DOI: 10.1186/s12967-024-05872-7.

Olfactory Epithelium Infection by SARS-CoV-2: Possible Neuroinflammatory Consequences of COVID-19.

Gutierrez-Garcia A, Contreras C Complex Psychiatry. 2024; 10(1-4):59-70.

PMID: 39545135 PMC: 11560153. DOI: 10.1159/000540982.

Mental health problems raise the odds of cognitive impairment in COVID-19 survivors.

Chakrabarty M, Chatterjee P, Mukherjee A, Das G, Mollah R, Mondal B Front Psychiatry. 2024; 15:1370085.

PMID: 39205850 PMC: 11349739. DOI: 10.3389/fpsyt.2024.1370085.

A Comprehensive Review on Navigating the Neurological Landscape of COVID-19: Insights Into Etiopathogenesis and Clinical Management.

Chavhan R, Wanjari A, Kumar S, Acharya S, Rathod N, Reddy H Cureus. 2024; 16(5):e60079.

PMID: 38860093 PMC: 11163389. DOI: 10.7759/cureus.60079.

Cognitive symptoms after COVID-19.

Altuna M, Sanchez-Saudinos M, Lleo A Neurol Perspect. 2024; 1:S16-S24.

PMID: 38620975 PMC: 8669718. DOI: 10.1016/j.neurop.2021.10.005.

References

Zhang J, Yang Z, Wang X, Li J, Dong L, Wang F . The relationship between resilience, anxiety and depression among patients with mild symptoms of COVID-19 in China: A cross-sectional study. J Clin Nurs. 2020; 29(21-22):4020-4029. PMC: 7404600. DOI: 10.1111/jocn.15425. View

Jasti M, Nalleballe K, Dandu V, Onteddu S . A review of pathophysiology and neuropsychiatric manifestations of COVID-19. J Neurol. 2020; 268(6):2007-2012. PMC: 7268182. DOI: 10.1007/s00415-020-09950-w. View

Ghannam M, Alshaer Q, Al-Chalabi M, Zakarna L, Robertson J, Manousakis G . Neurological involvement of coronavirus disease 2019: a systematic review. J Neurol. 2020; 267(11):3135-3153. PMC: 7304377. DOI: 10.1007/s00415-020-09990-2. View

Brann D, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B . Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020; 6(31). PMC: 10715684. DOI: 10.1126/sciadv.abc5801. View

Wei N, Huang B, Lu S, Hu J, Zhou X, Hu C . Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19. J Zhejiang Univ Sci B. 2020; 21(5):400-404. PMC: 7203540. DOI: 10.1631/jzus.B2010013. View

Achar A, Ghosh C . COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance. Cells. 2020; 9(11). PMC: 7692725. DOI: 10.3390/cells9112360. View

Cai X, Hu X, Ekumi I, Wang J, An Y, Li Z . Psychological Distress and Its Correlates Among COVID-19 Survivors During Early Convalescence Across Age Groups. Am J Geriatr Psychiatry. 2020; 28(10):1030-1039. PMC: 7347493. DOI: 10.1016/j.jagp.2020.07.003. View

Oussalah A, Gleye S, Urmes I, Laugel E, Barbe F, Orlowski S . The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study. EClinicalMedicine. 2020; 27:100554. PMC: 7502281. DOI: 10.1016/j.eclinm.2020.100554. View

Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y . Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics. 2002; 42(6):461-6. DOI: 10.1176/appi.psy.42.6.461. View

10.

Rosenbaum S, Stubbs B, Ward P, Steel Z, Lederman O, Vancampfort D . The prevalence and risk of metabolic syndrome and its components among people with posttraumatic stress disorder: a systematic review and meta-analysis. Metabolism. 2015; 64(8):926-33. DOI: 10.1016/j.metabol.2015.04.009. View

11.

Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L . Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2020; 93(2):1013-1022. DOI: 10.1002/jmv.26368. View

12.

Vilchinsky N, Ginzburg K, Fait K, Foa E . Cardiac-disease-induced PTSD (CDI-PTSD): A systematic review. Clin Psychol Rev. 2017; 55:92-106. DOI: 10.1016/j.cpr.2017.04.009. View

13.

Righy C, Rosa R, da Silva R, Kochhann R, Migliavaca C, Robinson C . Prevalence of post-traumatic stress disorder symptoms in adult critical care survivors: a systematic review and meta-analysis. Crit Care. 2019; 23(1):213. PMC: 6560853. DOI: 10.1186/s13054-019-2489-3. View

14.

Paterson R, Brown R, Benjamin L, Nortley R, Wiethoff S, Bharucha T . The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020; 143(10):3104-3120. PMC: 7454352. DOI: 10.1093/brain/awaa240. View

15.

Guo Q, Zheng Y, Shi J, Wang J, Li G, Li C . Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study. Brain Behav Immun. 2020; 88:17-27. PMC: 7235603. DOI: 10.1016/j.bbi.2020.05.038. View

16.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

17.

Hoffman L, Vilensky J . Encephalitis lethargica: 100 years after the epidemic. Brain. 2017; 140(8):2246-2251. DOI: 10.1093/brain/awx177. View

18.

Yang Y, Li W, Zhang Q, Zhang L, Cheung T, Xiang Y . Mental health services for older adults in China during the COVID-19 outbreak. Lancet Psychiatry. 2020; 7(4):e19. PMC: 7128970. DOI: 10.1016/S2215-0366(20)30079-1. View

19.

Becker W, Fiellin D . When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis. Ann Intern Med. 2020; 173(1):59-60. PMC: 7138333. DOI: 10.7326/M20-1210. View

20.

Jergovic M, Bendelja K, Savic Mlakar A, Vojvoda V, Aberle N, Jovanovic T . Circulating levels of hormones, lipids, and immune mediators in post-traumatic stress disorder - a 3-month follow-up study. Front Psychiatry. 2015; 6:49. PMC: 4396135. DOI: 10.3389/fpsyt.2015.00049. View